Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP). (COVID-19) - REMAP-CAP

niversity Medical Center Utrecht0 个研究点目标入组 20,000 人开始时间: 2015年7月13日最近更新: 2024年7月8日

适应症

试验速览

暂无简介。

•General REMAP-CAP Inclusion Criteria:
•1. Adult patient admitted to an ICU for acute severe CAP within 48 hours of hospital admission with
•a. symptoms or signs or both that are consistent with lower respiratory tract infection (for example, acute onset of dyspnea, cough, pleuritic chest pain) AND
•b. Radiological evidence of new onset infiltrate of infective origin (in patients with pre-existing radiological changes, evidence of new infiltrate)
•2. Up to 48 hours after ICU admission, receiving organ support with one or more of:
•a. Non-invasive or invasive ventilatory support;
•b. Receiving infusion of vasopressor or inotropes or both
•In order to be eligible to participate in the pandemic aspects of REMAP-CAP, a patient must meet the following criteria:
•1. Adult patient admitted to hospital with acute illness due to suspected or proven pandemic infection.
•This extension of the platform-level inclusion criteria can apply to patients admitted to an ICU or a ward. In association with the involvement of different clinical teams, the domains and interventions that are available for patients admitted to a ward compared with those admitted to an ICU are permitted to be, but do not have to be, different.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 2000
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 2000

•General REMAP-CAP Exclusion Criteria:
•1. Healthcare-associated pneumonia:
•a. Prior to this illness, is known to have been an inpatient in any healthcare facility within the last 30 days
•b. Resident of a nursing home or long-term care facility.
•2. Death is deemed to be imminent and inevitable during the next 24 hours AND one or more of the patient, substitute decision maker or attending physician are not committed to full active treatment.
•3. Previous participation in this REMAP within the last 90 days
•In order to be eligible to participate in the pandemic aspects of REMAP-CAP, a patient must meet the following criteria:
•1. Adult patient admitted to hospital with acute illness due to suspected or proven pandemic infection
•There are domain-specific exclusion criteria in the Antibiotic, macrolide duration, cortisteroid, antiviral, mechanical ventilation, Endothelial,Vit C, COVID-19 antiviral, COVID-19 immunomodulation, COVID-19 anticoagulation, COVID-19 antiplatelet, COVID-19 Simvastatin, COVID-19 ACE2 RAS, Immunoglobulin domains. Due to maximum number of characters, these are not listed separately.

发起方